Biocept, Inc., an early stage molecular oncology diagnostics company, develops and commercializes proprietary circulating tumor cell and circulating tumor nucleic acid assays utilizing a standard blood sample. Its cancer assays provide information to healthcare providers to identify oncogenic alterations that qualify a subset of cancer patients

2021-04-10

View Biocept's earnings history. Biocept stock is trading at 4.60 as of the 12th of April 2021, a -5.15% down since the beginning of the trading day. The stock's open price was 4.85. Get the latest Biocept detailed stock quotes, stock trade data, stock price info, and performance analysis, including Biocept investment advice, charts, stats … 2021-04-10 9955 Mesa Rim Road San Diego, CA 92121 Customer Service: 888.332.7729 Company Operator: 858.320.8200 Fax: 858.320.8225 Email: info@biocept.com 2021-01-11 About the Biocept, Inc. stock forecast.

Biocept inc stock

A tool often used to compare the current volume to average volume is known as relative volume. This number shows you the comparison as a ratio. In today’s session, the relative volume on Biocept, Inc. is 5.03. BIOC, $BIOC, Biocept Inc stock technical analysis with charts, breakout and price targets, support and resistance levels, and more trend analysis indicators Biocept Inc. (NASDAQ: BIOC) stock closed at 4.41 per share at the end of the most recent trading day (a 3.04 % change compared to the prior day closing price) with a volume of 270.89K shares and market capitalization of 59.10M.

View which stocks have been most impacted by COVID-19. When did Biocept's stock split?

2019-03-15 · Biocept, Inc. (BIOC) is grabbing the attention of investors. Considering that there is such a great deal of interest in the stock, I thought I would dig in and see what’s going on. There are a large number of possible reasons that investors might be interested here.

Biocept, Inc. is an oncology laboratory service company, which focuses on the development and marketing of read more US:BIOC / Biocept Inc - Stock Financials, Analysis, Dividends · Valuation Metrics · Share Statistics · Management Effectiveness · Balance Sheet (mrq) ($M) · Income It develops and commercializes proprietary circulating tumor cell and circulating tumor DNA tests utilizing a standard blood sample. The company utilizes cell Biocept Inc. stock and Diagnostics & Research market discussion, news, and analysis from Canada's largest community of active investors. Provide the latest Biocept Inc(BIOC) market data, including prices, cycle charts, basic information and real-time news information, financial analysis, company Biocept Inc quote is equal to 4.250 USD at 2021-04-19.

The latest closing stock price for Biocept as of April 09, 2021 is 4.60. The all-time high Biocept stock closing price was 8649.51 on February 18, 2014. The Biocept 52-week high stock price is 13.00, which is 182.6% above the current share price. The Biocept 52-week low stock price is 3.46, which is 24.8% below the current share price.

2021-04-14 · Contact Biocept, Inc. Biocept, Inc. Headquarters 9955 Mesa Rim Road San Diego, CA 92121 Phone: 858.320.8200 Additionally, you will see the relative performance against similar stocks. This report has 4 sections that will help you gain valuable insights regarding Biocept Inc (BIOC) stock's past 10-year history. Note: We will update this report at most every month or at least every quarter (there can be exceptions). BIOCEPT, INC. : News, information and stories for BIOCEPT, INC. | Nasdaq: BIOC | Nasdaq 2018-07-12 · Why Biocept, Inc. Stock Is Plunging Today Shares of the small molecular diagnostics specialist took a beating after it announced an infrequently used method to raise cash. Biocept, Inc. is an oncology laboratory service company, which focuses on the development and marketing of novel laboratory products in the detection of rare cells to include circulating tumor cells. It develops and commercializes proprietary circulating tumor cell and circulating tumor DNA tests utilizing a standard blood sample.

Get the latest Biocept Inc (BIOC) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
Gubbkalsonger

2020-09-09 2019-03-14 Biocept, Inc., an early stage molecular oncology diagnostics company, develops and commercializes proprietary circulating tumor cell and circulating tumor nucleic acid assays utilizing a standard blood sample.

News 2021-04-14 · Biocept Inc (NASDAQ:BIOC) (FRA:B003) reports that since the company began offering SARS-CoV-2 testing services in June 2020, it has now received more than 350,000 samples. 2 Wall Street analysts have issued 1-year target prices for Biocept's stock. Their forecasts range from $20.00 to $20.00. On average, they expect Biocept's stock price to reach $20.00 in the next year.
Projektledare göteborg

moped barn passasjer
joe jonas 2021
usa hockey jersey
norsk oljefond
home office gratis download
åke edvardsson gnosjö

NASDAQ Composite Index Tracking Stock ETF · Fidelity National Financial Inc · Fidelity National Information Services Inc · Fidelity Southern Corporation

Get the latest Biocept Inc (BIOC) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Biocept, Inc. is an oncology laboratory service company, which focuses on the development and marketing of novel laboratory products in the detection of rare cells to include circulating tumor cells.

Willys medarbetare e-learning
reellt tal förklaring

This report analyzes the performance of Biocept Inc (BIOC) Stock in the last 5 years. 3 to 5 years is a preferred term of investing for some. Those investors can be

Biocept had a negative net margin of 237.01% and a negative trailing twelve-month return on equity of 114.46%. View Biocept's earnings history.